NBOMes: Difference between revisions

From TripSit wiki
Jump to navigation Jump to search
No edit summary
m (Changed dosage table to use api)
 
(34 intermediate revisions by 6 users not shown)
Line 1: Line 1:
= General Information =
[[File:25c.jpg|thumb|300px|25C-NBOMe tabs dosed at 1mg each.]]


These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's strongly recommended to not take more than 1500 µg of any substance of the NBOMe family, as there have been multiple deaths from people taking just 2-3 blotters.


== History ==
== Dosage ==  
These chemicals have nearly no history of human use prior to 2010 when they first became available online.
Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.
The NBOMe family of chemicals is relatively new and very little is known about this group of compounds. These chemicals may only be used with extreme caution.


= 25I-NBOMe Dosage =
NBOMes were initially thought to be orally inactive, meaning they wouldn't work if swallowed. However, this is not the case for all NBOMes per se; certain NBOMe salts do have an observed oral bioavailability, with little known about the oral bioavailability of NBOMes in their freebase form. Therefore, when a substance might be an NBOMe, discard the blotter entirely rather than swallowing it, if you do not wish to risk being under the influence of an NBOMe. Oral administration is relatively uncommon and thus undocumented, presumably as a result of the existing confusion about the oral bioavailability of NBOMes. Sublingual administration is the most common, but buccal administration is recommended if you wish to avoid the generally bitter taste of NBOMes.


Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). NBOMe chemicals are not active orally, and will not work if swallowed. It is recommended to avoid sublingual administration because of the reported bad taste. Buccal administration is common, placing the tab between the upper or lower gum and lip.
The doses of NBOMes remain a controversial subject, as deaths have been reported at doses that were previously assumed acceptable. Please use caution, and in any case, '''do not exceed 1500µg'''!


== Sublingual ==
=== 25B-NBOMe ===  


Light: 200-500 micrograms
{{#tdose: 25B-NBOMe}}


Common: 500-1500 micrograms
=== 25C-NBOMe ===


Strong: 1500+ micrograms
{| class="wikitable"
|+ Sublingual
|-
| Light || 100-300 μg
|-
| Common || 300-800 μg
|-
| Strong || 800+ μg
|}


== Insufflated ==
=== 25I-NBOMe ===


Light: 100-400 micrograms
{| class="wikitable"
|+ Sublingual
|-
| Light || 200-500 μg
|-
| Common || 500-750 μg
|-
| Strong || 700-1000+ μg
|}


Common: 400-700 micrograms
{| class="wikitable"
|+ Insufflated
|-
| Light || 100-400 μg
|-
| Common || 400-700 μg
|-
| Strong || 700+ μg
|}


Strong: 700+ micrograms
== Duration ==


= 25C-NBOMe Dosage =
{| class="wikitable"
|+ Sublingual
|-
| Onset || 15-45 minutes
|-
| Total || 4-11 hours
|}


Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).
{| class="wikitable"
|+ Insufflated
|-
| Onset || 0-10 minutes
|-
| Total || 3-8 hours
|}


== Sublingual ==
== Effects ==


Light: 100-300 micrograms
=== Positive ===
 
Common: 300-800 micrograms
 
Strong: 800+ micrograms
 
== Insufflated ==
 
Low dose: 100-300 ug (micrograms!)
 
Medium (typical) dose: 300-500 ug (micrograms!)
 
High dose: >500 ug (micrograms!)
 
= Duration =
 
== Sublingual ==
 
Onset: 15-45 minutes
 
Total: 4-11 hours
 
== Insufflated ==
 
Onset: 0-10 minutes
 
Total: 3-8 hours
 
= Effects =
 
== Positive ==


* Strong open and closed eye visuals, including trails, color shifts, brightening, etc.
* Strong open and closed eye visuals, including trails, color shifts, brightening, etc.
Line 74: Line 80:
* Feelings of love and empathy
* Feelings of love and empathy


== Neutral ==
=== Neutral ===


* General change in consciousness
* General change in consciousness
Line 84: Line 90:
* Yawning, especially when coming up
* Yawning, especially when coming up


== Negative ==
=== Negative ===


Likelihood of negative side effects increases with higher doses.
Likelihood of negative side effects increases with higher doses.
Line 91: Line 97:
* Scrambled communication
* Scrambled communication
* Nausea
* Nausea
* Vasoconstriction
* Insomnia
* Insomnia
* Looping, recursive, out of control thinking
* Looping, recursive, out of control thinking
Line 97: Line 104:
* Unwanted life-changing spiritual experiences
* Unwanted life-changing spiritual experiences


== After effects ==
=== After effects ===


* Afterglow
* Afterglow
Line 105: Line 112:
**A relatively high rate of HPPD has been reported (all anecdotal data!) after the use of the NBOMe chemicals.
**A relatively high rate of HPPD has been reported (all anecdotal data!) after the use of the NBOMe chemicals.


= Harm Reduction =
== Harm Reduction ==
Do not attempt to operate heavy machinery, drive, ride a bike or do anything similar. Delayed reaction time and altering of your visual perception make these kind of activities unsafe.
 
NBOMes are considered less safe than many psychedelics due their heavy physical effects on the body, and as recreational dosages tend to overlap with what have been fatal dosages. Even so, many reports of death by an NBOMe chemical involve mislabeling of the drug, sometimes by the distributor (example: someone insufflates 20mg of 25I-NBOMe because he/she thought it was 2C-I). Mislabeling or misweighing can easily lead to extrememely dangerous, sometimes lethal, situations. Administration of an NBOMe in its powder form (either insufflated or otherwise) is strongly discouraged, as the potency is far greater than the accuracy of most scales.
 
Furthermore, due to the physical strain the drug causes one should not use it if there are any pre-existing heart conditions.
 
See [[Psychedelics#Harm_Reduction|Psychedelic Harm Reduction]] for general information.
 
== Images ==
 
<gallery mode="packed-hover" heights="150px">
Image:25b.jpg|''25B-NBOMe''
Image:25c.jpg|''25C-NBOMe''
Image:25i.jpg|''25I-NBOMe''
</gallery>
 


* Recommended time (pauses) between using the substance
== Legal status ==
**>2 weeks for a 100% tolerance reset, but the more time the better. You have only one body, be careful with it.


* Addiction potential
=== Europe ===
** So far no reports of addiction have surfaced.


* Risk of death
The NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011.<ref>http://www.rg.ru/2011/10/19/narko-dok.html</ref>
**Most reports of death by an NBOMe chemical involve mislabeling of the drug (for example: someone insufflates 20mg of 25i-NBOMe because he/she thought it was 2C-I). This chemical is extremely potent and has a relatively low LD50 (LD50 is the dosage at which 50% of the tested population does not survive). Therefore, a mislabeling can result in death.


* Mental illness
The UK Home Office announced that 25I-NBOMe would be made a class A drug on 10th June 2014 alongside every other N-benzyl phenethylamines.<ref>http://www.legislation.gov.uk/ukdsi/2014/9780111110904</ref>
**Do not use when you have a history of mental illness or a family history of mental illness (such as depression, schizophrenia, psychosis, bipolar disorder, etc.).


* Heart issues
=== America ===
**Do not use when you have a history of heart issues or a family history of heart issues.


= Legal =
25i-NBOMe, 25b-NBOMe, and 25c-NBOMe were emergency scheduled by the DEA on Novemeber 15, 2013<ref>http://www.justice.gov/dea/divisions/hq/2013/hq111513.shtml</ref>


== Europe ==
== Links ==


The NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011. See http://www.rg.ru/2011/10/19/narko-dok.html.
[https://en.wikipedia.org/wiki/NBOMe Wikipedia]


The UK Home Office announced that 25I-NBOMe would be made a class A drug on 10th June 2014 alongside every other N-benzyl phenethylamine. See http://www.legislation.gov.uk/ukdsi/2014/9780111110904.
[https://www.erowid.org/chemicals/nbome/ Erowid]


== America ==
[http://www.reddit.com/r/Drugs/comments/14wua3/rdrugs_faq_series_nbome_series_aka_25xnbome/?sort=top /r/Drugs FAQ]


The NBOMe series of compounds are unscheduled in the United States. It is possible that some of them would be considered analogs (of scheduled phenethylamines such as 2C-B or mescaline), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. However, Virginia has recently made the 25x-NBOMe series and all its analogues schedule I; expected is that more states are to follow quickly.
== References ==


<references />


[[Category:Psychedelic]]
[[Category:Psychedelic]]
[[Category:Drugs]]
[[Category:Drugs]]
[[Category:Research Chemical]]

Latest revision as of 10:33, 2 April 2019

25C-NBOMe tabs dosed at 1mg each.

These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's strongly recommended to not take more than 1500 µg of any substance of the NBOMe family, as there have been multiple deaths from people taking just 2-3 blotters.

Dosage

Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.

NBOMes were initially thought to be orally inactive, meaning they wouldn't work if swallowed. However, this is not the case for all NBOMes per se; certain NBOMe salts do have an observed oral bioavailability, with little known about the oral bioavailability of NBOMes in their freebase form. Therefore, when a substance might be an NBOMe, discard the blotter entirely rather than swallowing it, if you do not wish to risk being under the influence of an NBOMe. Oral administration is relatively uncommon and thus undocumented, presumably as a result of the existing confusion about the oral bioavailability of NBOMes. Sublingual administration is the most common, but buccal administration is recommended if you wish to avoid the generally bitter taste of NBOMes.

The doses of NBOMes remain a controversial subject, as deaths have been reported at doses that were previously assumed acceptable. Please use caution, and in any case, do not exceed 1500µg!

25B-NBOMe

{{#tdose: 25B-NBOMe}}

25C-NBOMe

Sublingual
Light 100-300 μg
Common 300-800 μg
Strong 800+ μg

25I-NBOMe

Sublingual
Light 200-500 μg
Common 500-750 μg
Strong 700-1000+ μg
Insufflated
Light 100-400 μg
Common 400-700 μg
Strong 700+ μg

Duration

Sublingual
Onset 15-45 minutes
Total 4-11 hours
Insufflated
Onset 0-10 minutes
Total 3-8 hours

Effects

Positive

  • Strong open and closed eye visuals, including trails, color shifts, brightening, etc.
  • Mood lift
  • Euphoria
  • Mental and physical stimulation
  • Increase in associative & creative thinking
  • Increased awareness & appreciation of music
  • Life-changing spiritual experiences
  • Erotic, sexual thoughts and sensations
  • Feelings of love and empathy

Neutral

  • General change in consciousness
  • Pupil dilation
  • Difficulty focusing
  • Unusual body sensations (facial flushing, chills, goosebumps, body energy)
  • Change in perception of time, time dilation
  • Slight increase in heart rate
  • Yawning, especially when coming up

Negative

Likelihood of negative side effects increases with higher doses.

  • Confusion
  • Looping
  • Scrambled communication
  • Nausea
  • Vasoconstriction
  • Insomnia
  • Looping, recursive, out of control thinking
  • Paranoia, fear, and panic
  • Unwanted and overwhelming feelings
  • Unwanted life-changing spiritual experiences

After effects

  • Afterglow
    • An afterglow may be present until a day after use, sometimes more depending on the individual.
  • Long term effects
    • A relatively high rate of HPPD has been reported (all anecdotal data!) after the use of the NBOMe chemicals.

Harm Reduction

NBOMes are considered less safe than many psychedelics due their heavy physical effects on the body, and as recreational dosages tend to overlap with what have been fatal dosages. Even so, many reports of death by an NBOMe chemical involve mislabeling of the drug, sometimes by the distributor (example: someone insufflates 20mg of 25I-NBOMe because he/she thought it was 2C-I). Mislabeling or misweighing can easily lead to extrememely dangerous, sometimes lethal, situations. Administration of an NBOMe in its powder form (either insufflated or otherwise) is strongly discouraged, as the potency is far greater than the accuracy of most scales.

Furthermore, due to the physical strain the drug causes one should not use it if there are any pre-existing heart conditions.

See Psychedelic Harm Reduction for general information.

Images

  • 25B-NBOMe

    25B-NBOMe

  • 25C-NBOMe

    25C-NBOMe

  • 25I-NBOMe

    25I-NBOMe


Legal status

Europe

The NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011.[1]

The UK Home Office announced that 25I-NBOMe would be made a class A drug on 10th June 2014 alongside every other N-benzyl phenethylamines.[2]

America

25i-NBOMe, 25b-NBOMe, and 25c-NBOMe were emergency scheduled by the DEA on Novemeber 15, 2013[3]

Links

Wikipedia

Erowid

/r/Drugs FAQ

References

  1. ↑ http://www.rg.ru/2011/10/19/narko-dok.html
  2. ↑ http://www.legislation.gov.uk/ukdsi/2014/9780111110904
  3. ↑ http://www.justice.gov/dea/divisions/hq/2013/hq111513.shtml
Retrieved from "http://wiki.tripsit.me/index.php?title=NBOMes&oldid=5782"